Recombinant Xylella fastidiosa Ribonuclease P protein component (rnpA)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your preferred format in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a guideline for your own preparations.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The specific tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
rnpA; PD_2122; Ribonuclease P protein component; RNase P protein; RNaseP protein; EC 3.1.26.5; Protein C5
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-135
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Xylella fastidiosa (strain Temecula1 / ATCC 700964)
Target Names
rnpA
Target Protein Sequence
MNSCKRFPRS ARICLPSEYY VAFEQGRRYS SVLLRLHHLP TSGPVRLGLV VSRRVDIRAV NRNRIKRALR EVMRQIAYKL VPGDYVVVVR QTAKDVSNAE LSVALLSLLR RIGALPLASI DNAMLPFFER NCSRK
Uniprot No.

Target Background

Function
RNase P catalyzes the removal of the 5'-leader sequence from pre-tRNA, generating the mature 5'-terminus. It also cleaves other RNA substrates, such as 4.5S RNA. The protein component plays a crucial auxiliary role in vivo; it binds to the 5'-leader sequence, enhancing the ribozyme's substrate specificity.
Database Links

KEGG: xft:PD_2122

Protein Families
RnpA family

Q&A

What is the genetic location and structure of the rnpA gene in Xylella fastidiosa?

The rnpA gene in Xylella fastidiosa codes for the protein component of Ribonuclease P (RNase P), an essential ribozyme responsible for processing the 5' end of precursor tRNA molecules. Based on comparative genomic analyses with other bacterial species like E. coli, the rnpA gene in X. fastidiosa is likely part of a conserved gene order. In E. coli, the rnpA gene is located in the dnaA region at 83 min of the E. coli K-12 map, with genes arranged in the clockwise orientation: rpmH (coding for ribosomal protein L34), rnpA (coding for the protein component of RNase P), followed by genes encoding a 60-kDal protein and a 50-kDal protein . This gene organization may be conserved in X. fastidiosa, though specific genomic mapping studies would be necessary to confirm this.

How does X. fastidiosa RNase P structure compare to RNase P in other bacterial species?

While specific structural data for X. fastidiosa RNase P remains limited, bacterial RNase P enzymes typically consist of a catalytic RNA component and a protein component (encoded by rnpA). The protein component in E. coli is a basic polypeptide with a molecular weight of approximately 13,773 Da . The X. fastidiosa rnpA protein likely shares structural similarities with other bacterial counterparts, particularly those from related plant pathogens. Comparative analysis with the E. coli rnpA protein could provide insights into conserved domains and functional regions, especially since bacterial RNase P proteins typically contain an RNA-binding domain that enhances substrate recognition.

What role might RNase P play in X. fastidiosa pathogenicity?

X. fastidiosa is a plant pathogen that causes economically important diseases across various crops . The bacterium's pathogenicity depends on several factors including colonization of plant xylem vessels and the production of virulence factors. While there is no direct evidence linking rnpA to X. fastidiosa virulence in the current literature, RNase P could potentially influence pathogenicity through:

  • Regulation of tRNA processing affecting protein synthesis rates during infection

  • Processing of other RNA species that might influence gene expression of virulence factors

  • Indirect effects on bacterial adaptation to the plant host environment

Research to explore these possibilities would require methods to modulate rnpA expression or activity in X. fastidiosa and assess resulting changes in bacterial virulence.

What expression systems are most effective for producing recombinant X. fastidiosa rnpA?

For successful expression of recombinant X. fastidiosa rnpA, researchers should consider the following expression systems and optimization strategies:

Table 1: Comparison of Expression Systems for Recombinant X. fastidiosa rnpA

Expression SystemAdvantagesDisadvantagesOptimization Notes
E. coli BL21(DE3)High yield, simple cultivation, well-established protocolsPotential for inclusion body formationConsider fusion tags (His6, GST); optimize induction temperature (16-25°C); use defined media
E. coli Rosetta™Enhanced expression of proteins with rare codonsHigher cost, potentially lower yieldImportant if X. fastidiosa rnpA contains rare codons based on codon usage analysis
Insect cell linesBetter folding of complex proteins, post-translational modificationsMore complex setup, higher cost, longer production timeConsider for cases where E. coli expression yields inactive protein
Cell-free systemsRapid expression, suitable for toxic proteinsLower yield, higher costUseful for initial screening of expression constructs

The choice of expression system should be guided by the intended application of the recombinant protein and requirements for functional activity. For structural studies requiring high purity and yield, E. coli systems often provide the most cost-effective approach when optimized properly.

What purification strategies work best for maintaining RNase P functional activity?

Purification of functionally active recombinant X. fastidiosa rnpA protein requires careful consideration of buffer conditions and purification steps:

  • Initial extraction: Use mild lysis conditions (e.g., lysozyme treatment followed by gentle sonication) in buffers containing 50 mM Tris-HCl pH 7.5-8.0, 300 mM NaCl, 5% glycerol, and 1-5 mM DTT to maintain reducing conditions.

  • Affinity chromatography: For His-tagged constructs, immobilized metal affinity chromatography (IMAC) using Ni-NTA or Co-based resins provides effective initial purification. Include 5-10 mM imidazole in binding buffers to reduce non-specific binding.

  • Buffer optimization: RNase P activity is typically dependent on divalent metal ions. Include 5-10 mM MgCl₂ in final storage buffers to maintain activity.

  • Activity preservation: Avoid freeze-thaw cycles by aliquoting the purified protein. Consider adding RNase inhibitors if RNA contamination is a concern during activity assays.

  • Quality control: Assess protein purity by SDS-PAGE and verify identity using Western blotting or mass spectrometry. Functional assays should be performed using standard RNase P substrates such as precursor tRNAs.

How can recombinant X. fastidiosa rnpA be used to develop detection methods for X. fastidiosa infections?

X. fastidiosa is a quarantine priority pest in Europe and many other countries, making reliable detection methods critically important . Recombinant rnpA protein could be utilized in several detection strategies:

  • Development of antibody-based detection: Purified recombinant rnpA can be used to generate specific antibodies for immunodetection methods such as ELISA or immunofluorescence.

  • Protein-RNA interaction studies: Recombinant rnpA could be used to study interactions with the RNA component of RNase P, potentially leading to RNA-based detection methods.

  • Functional assays as biomarkers: If unique enzymatic properties of X. fastidiosa RNase P are identified, these could serve as species-specific biomarkers.

  • Complementary approaches to current methods: Current detection methods for X. fastidiosa include qPCR (Harper's assay) and recombinase polymerase amplification (RPA) . Protein-based detection could complement these nucleic acid-based methods, especially in field conditions where protein stability might offer advantages.

What are the key considerations when designing experiments to analyze rnpA interaction with the RNA component of RNase P?

When studying the interaction between recombinant X. fastidiosa rnpA protein and the RNA component of RNase P, researchers should consider:

  • RNA preparation: The RNA component should be prepared using in vitro transcription with T7 RNA polymerase, followed by purification methods that preserve RNA structure (e.g., polyacrylamide gel electrophoresis).

  • Binding assays: Methods such as electrophoretic mobility shift assay (EMSA), filter binding assays, or surface plasmon resonance (SPR) can quantitatively assess protein-RNA interactions.

  • Experimental conditions: Buffer composition is critical - typically including 50 mM Tris-HCl (pH 7.5-8.0), 100 mM NH₄Cl, 10 mM MgCl₂, and 1-5% glycerol. Temperature and incubation times should be optimized.

  • Functional reconstitution: Assembly of functional holoenzyme can be verified using standard RNase P activity assays with precursor tRNA substrates.

  • Mutational analysis: Site-directed mutagenesis of both protein and RNA components can identify critical residues for interaction and catalysis.

Table 2: Experimental Design for Protein-RNA Interaction Studies

MethodPrincipleAdvantagesLimitationsData Analysis Approach
EMSAAltered migration of RNA when bound to proteinSimple setup, visually interpretableSemi-quantitative, potential dissociation during electrophoresisDensitometry analysis, calculation of apparent Kd
Filter bindingRetention of RNA-protein complexes on nitrocelluloseQuantitative, requires small amounts of materialPotential non-specific bindingScatchard analysis, determination of binding constants
SPRReal-time detection of binding using immobilized componentsLabel-free, kinetic measurements possibleExpensive equipment, potential surface effectsAssociation/dissociation rate constants, equilibrium constants
Fluorescence anisotropyChange in rotational freedom upon bindingReal-time measurements in solutionRequires fluorescent labelingBinding curves, determination of Kd values

What are common challenges when working with recombinant X. fastidiosa rnpA and how can they be addressed?

Researchers working with recombinant X. fastidiosa rnpA may encounter several challenges:

Table 3: Troubleshooting Guide for Recombinant X. fastidiosa rnpA Work

ChallengePossible CausesSolutions
Poor expression yieldCodon usage bias, protein toxicity, improper inductionOptimize codon usage, use expression strains with rare tRNAs, reduce induction temperature, use tightly controlled promoters
Protein insolubilityImproper folding, hydrophobic regions, aggregationExpress as fusion with solubility tags (MBP, SUMO), reduce induction temperature to 16-18°C, include solubilizing agents (0.1% Triton X-100, 1M urea) in lysis buffer
Loss of activity during purificationOxidation of critical residues, removal of essential cofactorsInclude reducing agents (5mM DTT or 2mM β-mercaptoethanol), avoid metal chelators like EDTA if divalent metals are required for activity
Inconsistent activity assaysVariable substrate quality, buffer composition issuesStandardize substrate preparation, include internal controls, optimize assay conditions (pH, ionic strength, divalent cation concentration)
Protein-RNA complex instabilitySuboptimal buffer conditions, RNase contaminationInclude RNase inhibitors, optimize salt concentration and pH, consider cross-linking approaches for structural studies

How should researchers analyze and interpret kinetic data for recombinant X. fastidiosa RNase P activity?

Analysis of kinetic data for recombinant X. fastidiosa RNase P requires:

  • Proper experimental design:

    • Use a range of substrate concentrations spanning at least 0.2-5 times the Km

    • Include appropriate controls (no enzyme, heat-inactivated enzyme)

    • Ensure linear reaction rates by taking multiple time points

  • Kinetic models and parameters:

    • For standard Michaelis-Menten kinetics, determine Km and kcat using non-linear regression

    • For complex kinetics (e.g., substrate inhibition, cooperativity), apply appropriate modified models

    • Calculate catalytic efficiency (kcat/Km) for comparing enzyme variants or conditions

  • Statistical analysis:

    • Perform experiments in triplicate (minimum) to calculate standard deviation and standard error

    • Use appropriate statistical tests (t-test, ANOVA) to determine significance of observed differences

    • Calculate 95% confidence intervals for key parameters

  • Data presentation recommendations:

    • Present raw data as well as fitted curves

    • Include Lineweaver-Burk or Eadie-Hofstee plots as visual aids, but rely on non-linear regression for parameter determination

    • Report both means and measures of variability (standard deviation or standard error)

How does X. fastidiosa rnpA compare to homologs in related bacterial pathogens?

Understanding the evolutionary relationships and functional conservation of rnpA across species can provide insights into X. fastidiosa biology. Based on comparative analysis with E. coli rnpA, researchers should consider:

  • Sequence conservation analysis: Alignment of rnpA sequences from X. fastidiosa, E. coli, and other plant pathogens can reveal conserved domains and species-specific features .

  • Genomic context: In E. coli, rnpA is part of a gene cluster including rpmH (encoding ribosomal protein L34) . Examining whether this genomic organization is conserved in X. fastidiosa and other species can provide insights into evolutionary relationships.

  • Structural predictions: Homology modeling based on known bacterial RNase P protein structures can predict key functional regions in the X. fastidiosa protein.

  • Functional complementation: Experiments testing whether X. fastidiosa rnpA can complement E. coli rnpA mutants would provide valuable insights into functional conservation.

What bioinformatic tools are most useful for analyzing X. fastidiosa rnpA in comparative studies?

Researchers conducting comparative genomic analyses of X. fastidiosa rnpA should consider these bioinformatic approaches:

  • Sequence alignment tools:

    • MUSCLE or CLUSTAL for multiple sequence alignments

    • T-COFFEE for incorporating structural information into alignments

    • HMMER for profile-based searches to identify distant homologs

  • Phylogenetic analysis:

    • MEGA or PhyML for constructing phylogenetic trees

    • MrBayes for Bayesian phylogenetic inference

    • IQ-TREE for maximum likelihood phylogeny with model testing

  • Structural analysis:

    • SWISS-MODEL or Phyre2 for homology modeling

    • ConSurf for mapping conservation onto protein structures

    • PredictProtein for identifying functional sites and secondary structure

  • Genomic context analysis:

    • NCBI Genome Browser or PATRIC for visualizing gene neighborhoods

    • MicrobesOnline for comparative genomic context analysis across multiple species

    • IslandViewer for identifying genomic islands that might indicate horizontal gene transfer

What novel approaches could advance our understanding of X. fastidiosa RNase P function?

Emerging technologies and methodologies that could advance X. fastidiosa RNase P research include:

  • CRISPR-Cas9 gene editing: Developing methods for targeted modification of rnpA in X. fastidiosa to study the effects on growth, virulence, and RNA processing.

  • High-throughput RNA sequencing: Applying RNA-seq to identify all RNA substrates processed by RNase P in X. fastidiosa, potentially uncovering novel non-tRNA substrates.

  • Cryo-electron microscopy: Determining high-resolution structures of X. fastidiosa RNase P holoenzyme to understand the molecular basis of its function.

  • Single-molecule approaches: Using techniques like FRET to study the dynamics of RNase P-substrate interactions in real-time.

  • Synthetic biology: Engineering modified RNase P enzymes with altered substrate specificity or enhanced activity against specific targets.

How might understanding X. fastidiosa RNase P contribute to disease management strategies?

Research on X. fastidiosa RNase P could lead to novel disease management approaches:

  • Targeted inhibitors: If unique features of X. fastidiosa RNase P are identified, specific inhibitors could be developed as potential antimicrobials.

  • Diagnostic tools: RNase P-based detection methods could complement current approaches like qPCR and RPA for early detection of X. fastidiosa infections .

  • Resistant varieties: Understanding how host plants interact with bacterial components could inform breeding programs for resistant crop varieties.

  • Ecological control: Knowledge of X. fastidiosa RNA processing might reveal vulnerable points in the bacterial life cycle that could be targeted for ecological control strategies.

  • Predictive modeling: Incorporating molecular data on essential functions like RNase P activity into models predicting X. fastidiosa spread and virulence.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.